Tandem mass spectrometry in newborn screening

Endocrinologist

Volumn 12, Issue 1, 2002, Pages 50-57

  Matern, Dietrich ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; AMINO ACID; CARBOXYLIC ACID; FATTY ACID;

AMINO ACID ANALYSIS; BLOOD ANALYSIS; BLOOD STAIN; FATTY ACID METABOLISM; HUMAN; INBORN ERROR OF METABOLISM; METABOLIC DISORDER; NEWBORN; NEWBORN SCREENING; PROGNOSIS; REVIEW; TANDEM MASS SPECTROMETRY;

EID: 0036146927     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019616-200201000-00011     Document Type: Review

References (43)

1. The first treatment of phenylketonuria
2. The introduction of newborn screening for phenylketonuria. A personal history
3. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants
4. Tandem mass spectrometry: A new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism
5. The role of tandem mass spectrometry in the diagnosis of fatty acid oxidation disorders
6. Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry
7. Rapid diagnosis of maple syrup urine disease in blood spots from newborns by tandem mass spectrometry
8. Isovaleric acidemia: A new genetic defect of leucine metabolism
9. Mass spectrometry methods for metabolic and health assessment
10. Rapid diagnosis of homocystinuria and other hypermethioninemias from newborns' blood spots by tandem mass spectrometry
11. Rapid diagnosis of MCAD deficiency: Quantitatively analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry
12. Use of phenylalanine-to-tyrosine ratio determined by tandem mass spectrometry to improve newborn screening for phenylketonuria of early discharge specimens collected in the first 24 hours
13. Laboratory integration and utilization of tandem mass spectrometry in neonatal screening: A model for clinical mass spectrometry in the next millennium
14. Using tandem mass spectrometry for metabolic disease screening among newborns - A report of a work group
15. Medium chain acyl-CoA dehydrogenase deficiency in Pennsylvania: Neonatal screening shows high incidence and unexpected mutation frequencies
16. Rapid diagnosis of MCAD deficiency - Quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry
17. Rapid diagnosis of methylmalonic and propionic acidemias: Quantitative MS/MS analysis of propionylcarnitine in filter paper blood specimens obtained from newborns
18. Diagnosis of mitochondrial trifunctional protein deficiency in a blood spot from the new-born screening card by tandem mass spectrometry and DNA analysis
19. Automated tandem mass spectrometry for mass newborn screening for disorders in fatty acid, organic acid, and amino acid metabolism
20. Multiple acyl-coenzyme A dehydrogenase deficiency: Diagnosis by acyl-carnitine analysis of a 12-year-old newborn screening card
21. Newborn screening with tandem mass spectrometry: 12 Months' experience in NSW Australia
22. Multiple acylcoA-dehydrogenase deficiency (MADD): Use of acylcarnitines and fatty acids to monitor the response to dietary treatment
23. Detection of neonatal carnitine palmitoyltransferase II deficiency by expanded newborn screening with tandem mass spectrometry
24. Clinical applications of tandem mass spectrometry: Ten years of diagnosis and screening for inherited metabolic diseases
25. Carnitine transporter defect diagnosed by newborn screening with electrospray tandem mass spectrometry
26. Diagnosis of very long chain acyl-CoA dehydrogenase deficiency from an infant's newborn screening card
27. 2-Methylbutyryl-coenzyme A dehydrogenase deficiency: A new inborn error of L-isoleucine metabolism
28. Ethylmalonic aciduria: An organic acidemia with CNS involvement and vasculopathy
29. Diagnosis of isovaleric acidaemia by tandem mass spectrometry: False positive result due to pivaloylcarnitine in a newborn screening programme
30. Prenatal diagnosis of disorders of fatty acid transport and mitochondrial oxidation
31. Fatty acid oxidation disorders
32. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Diagnosis by acylcarnitine analysis in blood
33. The metabolic autopsy comes of age
34. Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death
35. Medium-chain acyl-CoA dehydrogenase deficiency: Sudden and unexpected death of a 45 year old woman
36. Sudden and unexpected neonatal death: A protocol for the postmortem diagnosis of fatty acid oxidation disorders
37. The magnitude and challenge of false-positive newborn screening test results
38. Analysis of 17-hydroxy progesterone (17OHP) by tandem mass spectrometry (MS/MS) for the detection of congenital adrenal hyperplasia (CAH) in newborn blood spots
39. A rapid screening procedure for the diagnosis of peroxisomal disorders: Quantification of very long-chain fatty acids, as dimethylaminoethyl esters, in plasma and blood spots, by electrospray tandem mass spectrometry
40. Analysis of guanidinoacetate and creatine by isotope dilution electrospray tandem mass spectrometry
41. Determination of acid alpha-glucosidase activity in blood spots as a diagnostic test for Pompe disease
42. Direct analysis of filter paper blood specimens for identification of Smith-Lemli-Opitz syndrome using time-of-flight secondary ion mass spectrometry